Walleye Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Walleye Trading’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,663	Closed	-$162K	–	5911
2022 Q1	$162K	Buy	+4,663	New	+$139K	﹤0.01%	3962
2021 Q4	–	Sell	-5,971	Closed	-$185K	–	6155
2021 Q3	$152K	Sell	5,971 -19,252	-76%	-$566K	﹤0.01%	4104
2021 Q2	$883K	Buy	25,223 +11,082	+78%	+$433K	﹤0.01%	2270
2021 Q1	$576K	Sell	14,141 -63,839	-82%	-$2.93M	﹤0.01%	2502
2020 Q4	$3.38M	Buy	77,980 +72,672	+1,369%	+$3.58M	0.01%	990
2020 Q3	$293K	Buy	+5,308	New	+$337K	﹤0.01%	2684
2018 Q1	–	Sell	-523	Closed	-$21	–	4904
2017 Q4	$21	Buy	+523	New	+$19.5K	﹤0.01%	4171

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's GBT Position: Q2 2022 in Review

Walleye Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 4,663 shares — an estimated $162K sold.

Walleye Trading first reported a position in GBT in Q4 2017 and held it in 7 quarters. The position peaked at $3.38M in Q4 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

Walleye Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
Walleye Trading sold 4,663 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $162K.
Walleye Trading first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 7 quarters.
Walleye Trading's Global Blood Therapeutics, Inc. position peaked at $3.38M in Q4 2020.
195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.